Israeli Medical Technology Firm to Establish US Headquarters and Create 100 Jobs in Manatee County

A growing Israel-based medtech company plans to open its U.S. headquarters in Manatee County.

Orthopedics company Ossio recently began converting 30,000 square feet of leased space in Palmetto for a manufacturing plant and surgeon training center, according to a statement.

The company makes metal-free fixation implants out of a proprietary material that allows for bone regeneration. Fixation implants — which usually include things like screws, plates, and pins — are designed to set and stabilize bones.

The decision to open a manufacturing plant and surgeon training center in the United States comes as the company faces increasing demand for its products here, Ossio CEO Brian Verrier says in an email to the Business Observer.

“The U.S. is our primary focus, and the business has grown significantly over the last 5 years based on exceptional demand from U.S. orthopedic surgeons,” Verrier says.

From Ossio’s first product launch in 2019 through September 2025, more than 60,000 of its implants have been used to treat orthopedic patients in the U.S, according to Verrier. “Our move to put in place U.S. manufacturing solves for our capacity needs over the next several years and brings our manufacturing closer to our customer base,” Verrier states.

Currently, the company’s development and manufacturing headquarters is in Caesarea, Israel. Meanwhile, its commercial headquarters is in Boston.

“In general, our new products transferring out of our R&D program and into manufacturing at scale will remain in Israel and our more stable/higher-volume products will be manufactured in Palmetto,” Verrier says. Having two sites for manufacturing “ensures business continuity if one site goes offline for any reason.”

The effort to increase production has been planned for some time. Ossio raised more than $27 million in equity funding last December to rapidly scale all its commercial efforts, including building out this flagship site in north Manatee County, according to the statement.

‘Attractive combination’

Several factors led the company to select its new location at Florida International Tradeport, an industrial park spanning two million square feet along Interstate 75 near the US 301 interchange in north Manatee County.

“Florida fosters a culture of innovation in health care and life sciences…” Verrier states. “The Tampa region in particular offers medical technology companies like ours an attractive combination of technical talent and economic incentives to support sustainable growth.”

The Ossio facility will create approximately 100 jobs over the next five years, according to the statement. The company plans to begin recruiting for manufacturing technicians, clinical trainers, and support staff this fall and start producing its metal-free implants in spring 2026.

Additionally, Verrier mentions that the company trains 150 to 200 surgeons a year, collaborating on ways Ossio’s technology can improve surgical outcomes for a variety of clinical indications.

“The addition of Ossio to our health technology sector will directly elevate Florida’s life sciences job and innovation outcomes,” Florida Secretary of Commerce J. Alex Kelly points out in the statement.

Proprietary tech

Demand for the company’s products is growing “because of strong patient and surgeon preference to avoid the concerns and complications of metal fixation implants,” Ossio says in the statement.

According to the company’s website, metal implants can lead to pain, allergic reactions, and weakening of surrounding bones, and one in four people has metal implants removed in a second operation.

“Many areas of orthopedics have seen tremendous innovation,” Verrier notes, highlighting advancements in robotics surgery and joint replacements. “On the other hand, metal fixation has been the standard of care since before the Civil War.”

Verrier adds, “Ossio did not create the need but solved a difficult materials and engineering challenge by delivering rivaling mechanical strength vs. metal and a very desirable and safe biocompatibility profile.”

The special polymeric mineral fiber matrix Ossio uses in its proprietary implants allows for rapid bone in-growth, regeneration, and replacement, offering a “new way for orthopedic surgeons to restore their patients’ stability and mobility while leaving nothing permanent behind,” the statement reveals.

Next, the company plans to continue developing additional applications for its implants across all major segments of orthopedics, with the orthopedic fixation market valued at more than $15 billion.

Key Information

• Company: Ossio
• Location: Palmetto, Florida
• Facility Size: 30,000 square feet
• Jobs Created: Approximately 100 over the next five years
• Production Start: Spring 2026
• Investment: Raised over $27 million in equity funding
• Market Value: Orthopedic fixation market is over $15 billion